Autoimmune Encephalitis Subtypes Identified in Rapidly Progressive Dementia

Rapidly progressive dementia (RPD) presents a formidable diagnostic challenge, defined by a swift cognitive decline over weeks to months that can arise from a wide range of etiologies [1, 2]. While clinicians often consider neurodegenerative conditions such as Creutzfeldt-Jakob disease, autoimmune encephalitis (AE) is an increasingly recognized and critical differential diagnosis [1, 2]. The significance of AE lies in its potential responsiveness to treatment; unlike many causes of RPD, the prompt initiation of immunomodulatory therapy can lead to substantial clinical improvement and may prevent irreversible neurological injury [1, 3, 4, 5]. However, the varied clinical presentations of AE frequently mimic other dementias, complicating the diagnostic process and risking treatment delays [6, 7]. A recent study provides needed clarity by characterizing the specific clinical features and subtypes of AE that manifest as RPD.